Compare PepsiCo, Inc. (PEP) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PepsiCo, Inc. vs 22nd Century Group Inc — how do they compare? PepsiCo, Inc. trades at $126.04 (market cap $174.89B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: PepsiCo, Inc. is far larger — about 281322.9× 22nd Century Group Inc's market cap, and PepsiCo, Inc. pays a 4.61% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold PepsiCo, Inc. for 107 Days and 22nd Century Group Inc for 32 Days on average.
| PEP | XXII | |
|---|---|---|
Market Cap | $174.89B | $621.67K |
Volume | 23,968,864 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $170.44 | $483.00 |
52-Week Low | $123.64 | $0.80 |
Typical Hold Time | 107 Days | 32 Days |
Enterprise Value | $215.61B | -$3.69M |
Dividend Yield | 4.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $125.97, up 1.88% today, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q3 2026 EPS of $2.34 exceeding the $2.29 estimate. Revenue grew to $93.93B in 2025, though net income margin dipped to 8.77%. Analysts maintain a consensus price target of $146.77, implying significant upside. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while institutional holdings saw mixed adjustments.
The outlook for PEP is cautiously optimistic, driven by earnings momentum and a reasonable P/E of 16.14. Risks include competitive pressures and sensitivity to consumer spending. The stock offers a dividend yield near 4%, supporting income-focused investors. Upside potential exists if North American performance improves, but volatility may persist amid macroeconomic uncertainties.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
